Apollon Papadimitriou
Chief Executive Officer at iOmx Therapeutics AG
Profile
Apollon Papadimitriou is currently the Chief Executive Officer at iOmx Therapeutics AG.
He started this position in 2019.
Prior to his current role, he obtained a doctorate degree from Julius-Maximilians-Universität Würzburg in 1995.
Apollon Papadimitriou active positions
| Companies | Position | Start |
|---|---|---|
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Chief Executive Officer | 01/07/2019 |
Training of Apollon Papadimitriou
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Health Technology |
- Stock Market
- Insiders
- Apollon Papadimitriou
